Omid Tehrani, M.D. – FDA Inspection, Apr 14, 2022

Record Details

This FDA Inspection record concerns Omid Tehrani, M.D., with an inspection on April 14, 2022, issued by the Center for Drug Evaluation and Research, covering drugs.

Company: Omid Tehrani, M.D.
Inspection Date: April 14, 2022
Product Type: Drugs
Office: Center for Drug Evaluation and Research

View Company Profile

ID · 7245784b-6d48-4ad5-aed8-139ea9595b03

Inspection Facts

Voluntary Action Indicated (VAI)

Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.

Inspection number: 1168082
FDA center: Human Drugs
Project area: Bioresearch Monitoring

FDA Citations

21 CFR 312.60FD-1572, protocol compliance
21 CFR 312.62(b)Case history records- inadequate or inadequate

Full citation text and observation details available on the Dashboard.

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Omid Tehrani, M.D.

FDA Inspection

Omid Tehrani, M.D.April 14, 2022